Alere To Appoint Veteran Finance Executive, James F. Hinrichs, EVP And Chief Financial Officer

WALTHAM, Mass., March 23, 2015 /PRNewswire/ -- Alere Inc. (NYSE: ALR), a global leader in rapid diagnostics, today announced that James F. ("Jim") Hinrichs will be appointed Executive Vice President and Chief Financial Officer, effective April 6, 2015, with global responsibility for Finance, Procurement, IT and Shared Services. Hinrichs succeeds David ("Dave") Teitel who will remain with the Company during a transition period.

Hinrichs joins Alere with nearly 25 years of experience in financial and executive leadership roles across the healthcare industry. He most recently served as the CFO of CareFusion, a leading, global medical device company headquartered in San Diego, CA. During his tenure at CareFusion, Hinrichs played a key role in helping build the company to become a market leader in anesthesia delivery, infection prevention and infusion medical devices.

"Jim is a proven leader with a track record of success, exceptional leadership capabilities and cultural values that align with those of the Alere team," said Namal Nawana, Chief Executive Officer and President of Alere. "We are pleased to have someone of his caliber join our executive leadership team and are confident that Jim's extensive financial, strategic, and industry experience will further accelerate Alere towards sustainable growth and strong financial performance."

"Alere has benefitted tremendously from Dave's leadership over the past 11 years," continued Nawana. "He has played a vital role in the Company's recent transformation and has helped establish a solid financial and operational foundation for Alere. On behalf of the entire organization, I would like to thank Dave for his many accomplishments as CFO. We are pleased that he will remain with the Company during the transition, and we look forward to continuing to benefit from his expertise and institutional knowledge."

"I'm very pleased to be joining the Alere team during this exciting time," said Jim Hinrichs. "Under Namal and the rest of the executive team's leadership, the Company is rapidly transforming to a faster growing, higher profit entity while helping patients around the globe. I believe there is a tremendous opportunity at Alere to build one of the industry's best performing, most valuable companies and I'm excited to be a part of the journey with the team."

About Jim Hinrichs
Prior to his appointment as CFO of Alere, Jim Hinrichs served in the role of CFO at CareFusion Corp., a global medical technology corporation, since 2010. He held this position through the completion of Becton Dickinson's acquisition of CareFusion in March 2015. Prior to this role, Hinrichs served as SVP of Global Customer Support and, before that, Corporate Controller of CareFusion. Previously, he served as Executive Vice President and Controller of Cardinal Health, CFO of Cardinal Health's Clinical and Medical Products segment and the CFO of Cardinal Health's Healthcare Supply Chain Services segment, at the time a multinational business generating annual revenues in excess of $80 billion. He joined Cardinal Health in February 2004 following 12 years of finance and marketing roles at Merck & Co. and two years as the CFO of SangStat Medical Corporation, a global biopharmaceutical company, which was acquired by Genzyme Corp. in 2003. Hinrichs holds undergraduate and graduate degrees in Business from Carnegie Mellon University.

About Alere
Because Knowing now matters, Alere delivers reliable and actionable information through rapid diagnostic tests, resulting in better clinical and economic healthcare outcomes globally. Headquartered in Waltham, Mass., Alere focuses on rapid diagnostics for infectious disease, cardiometabolic disease and toxicology. For more information on Alere, please visit www.alere.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/alere-to-appoint-veteran-finance-executive-james-f-hinrichs-evp-and-chief-financial-officer-300054152.html

SOURCE Alere Inc.